Cited by 17Opioid Use Disorder TreatmentPoisoning and overdose treatmentsSubstance Abuse Treatment and Outcomes

Polydrug epidemiology: benzodiazepine prescribing and the drug overdose epidemic in the United States

Zoorob, Michael James·2018·Pharmacoepidemiology and Drug Safety

Abstract

BACKGROUND: Although polydrug incidents comprise a substantial proportion of overdose deaths, scholarly and popular focus has centered on prescription opiates. This study examines the role of benzodiazepine and opioid prescriptions on overdose-both individually and synergistically-using data from Medicare Part D, a source of prescription drug claims for about 35 million Americans. METHODS: Prescribing data from the Medicare Part D Public Use Files for 2013, 2014, and 2015 (approximately 3.5 billion prescription drug claims) are geolocated using the prescriber's national provider identifier to calculate the proportion of claims for opioids and benzodiazepines in each county. These rates are matched with overdose data and controls to compile an analytic dataset of 9105 county-years. Multinomial logistic regression is used to estimate the probability that a county experiences higher rates of overdose fatalities. RESULTS: A 1% increase in the benzodiazepine proportion of claims is associated with 1.2 odds of high, versus low, overdose (P < .1) and 1.4 odds of very high overdose (P < .05). Moreover, there was a substantial interaction between opioids and benzodiazepines (P < .001). A county with 6% benzodiazepine prescriptions and 12% opioid prescriptions has a .58 predicted probability of very high overdose, significantly higher (P < .001) than the .33 probability for a county with 12% opioid prescriptions but 3% benzodiazepine prescriptions. CONCLUSION: These findings shed light on the polydrug epidemiology of the overdose epidemic. Overdose deaths are highest where elevated opioid and benzodiazepine claims coexist. Overdose levels may reflect polydrug use and misuse, requiring clinical and policy responses beyond reducing opioid prescriptions.

Integrity signals

Registry

Crossref · 10.1002/pds.4417

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zoorob, M. J.
Affiliations
Harvard University (US)
Corresponding author
Zoorob, Michael James
Venue
Pharmacoepidemiology and Drug Safety
Publisher
Wiley
Published
2018-03-14
Volume
27
Issue
5
Pages
541-549
ISSN
  • 1053-8569 (ISSN-L)
  • 1099-1557
OpenAlex
W2791500306
Cited by
17
References
40
Citations by year
2026: 2 · 2025: 1 · 2024: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 6 · 2018: 1
FWCI
2.62
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmacoepidemiology and Drug Safety (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
polydrug use, benzodiazepine prescribing, opioid prescribing, drug overdose, prescription drug misuse, drug overdose deaths, Medicare Part D claims
MeSH terms
Analgesics, Opioid, Benzodiazepines, Humans, Drug Prescriptions, Psychotropic Drugs, Socioeconomic Factors, United States, Pharmacoepidemiology, Polypharmacy, Medicare Part D, Prescription Drugs, Epidemics, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review